Observing Optimal Treatment Strategies in Ovarian Cancer in Ohio

Podcast

We recently traveled to Columbus, Ohio for a State of the Science Summit™ on Ovarian Cancer, which featured insights from The Ohio State University Comprehensive Cancer Center–James faculty.

We recently traveled to Columbus, Ohio for a State of the Science Summit™ on Ovarian Cancer. At the meeting, faculty from The Ohio State University Comprehensive Cancer Center—James, discussed the importance of performing genetic testing upon diagnosis, shared insight on the evolution of ovarian cancer therapeutics, and provided perspective on individualized approaches in the frontline setting.

Additionally, panelists highlighted selection criteria for surgical procedures in ovarian cancer, contextualized the role of secondary surgery in the recurrent setting, and shed light on real-world evidence with PARP inhibitors in this space.

Interested in attending an upcoming OncLive® State of the Science Summit in your area? Register today.

Related Videos
Amin Nassar, MD
Samilia Obeng-Gyasi, MD, MPH,
Emil Lou, MD, PhD, FACP
Bradley R. Corr, MD, associate professor, LeBert Suess Family Endowed Professor in Ovarian Cancer Research, gynecologic oncology team, the University of Colorado Anschutz Medical Campus
Hye Sook Chon, MD, gynecologic oncologist, Gynecologic Oncology Program, Moffitt Cancer Center
Amma Asare, MD, PhD
Laura J. Chambers, DO
Casey M. Cosgrove, MD